SolasCure’s mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds.
Aurase Wound Gel aims to be a breakthrough in wound bed preparation for patients with chronic wounds
Every year ~85 million people suffer from chronic wounds worldwide
Aurase Wound Gel, a hydrogel containing the proteolytic enzyme Tarumase, aims to facilitate debridement, reduce bacterial biofilm, and promote wound bed preparation and healing.
Tarumase is a recombinantly produced version of the key protease deployed by larvae in wounds to break down necrotic tissue.
A product of evolution, Tarumase is highly effective and does not provoke allergenic responses unlike many other proteases.
Lily is a trained biologist and has led global
SolasCure aims to support healthcare professionals with wound care products
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.